Stay updated on 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Sign up to get notified when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.

Latest updates to the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check20 days agoChange DetectedAn NIH site announcement explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.8%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record history now shows a new Revision: v3.7.0, replacing the previous v3.6.6, indicating an update to the history-tracking interface.SummaryDifference0.1%

- Check77 days agoChange DetectedThe revision history now includes a new entry for v3.6.6 and removes the previous v3.6.5, reflecting an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.